Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer

Table 7

Immunorecognition of 14F7 Mab in nontumoral and nasopharyngeal carcinoma.

Histopathological classification	14F7 Mab reactivity
	No. of cases (%)	Intensity range	% of positive cells
Nontumoral tissues
Normal	0/2 (0)	−	−
Dysplasia	1/1 (100)	+	3
Squamous cell carcinoma (SCC)
In situ	2/2 (100)	+/++	1/3
Well	4/4 (100)	++/+++	1–3
Moderately	3/3 (100)	+/+++	1–3
Poorly	5/6 (83.3)	+/++/+++	1–3
Undifferentiated	1/1 (100)	+++	3
Total (SCC)	13/14 (92.8)

Intensity: − negative, + weak, ++ moderate, +++ intense. Positive cells: 0 (negative to less than 5%), 1 (6–25%), 2 (26–50%) and 3 (more than 50%).